UroStream

Editor’s note: PARP inhibitors (PARPi) have become key agents in the treatment of metastatic castration-resistant prostate cancer (mCRPC), marking the beginning of precision oncology in this field. At the 2025…

At ASCO and EAU 2025, Professor Shouzhen Chen (Qilu Hospital, Shandong University) shared an in-depth overview of molecular subtyping in mCRPC. He emphasized established targets like HRR and MSI-H,…

In a thought-provoking panel discussion, leading Chinese experts Drs. Zhou Liangping, Wang Qifeng, Yong Jia, and Qi Ma tackled several pressing issues in prostate cancer care. The conversation spanned diagnostic…

Editor’s Note: Urothelial carcinoma (UC) is one of the most common malignancies of the urinary system. For early-stage non–muscle-invasive disease, treatment typically involves transurethral resection of bladder tumor (TURBt) followed…

Editor’s note: In recent years, antibody-drug conjugates (ADCs) targeting various molecules and using novel payloads have led to significant breakthroughs in the treatment of metastatic urothelial carcinoma (mUC). The combination…

Editor’s Note: The 2025 Annual Meeting of the Chinese Urological Association (CUDA) was successfully held from June 12 to 15 in the coastal city of Zhuhai. With the theme “Healthy…

The 2025 Annual Meeting of the Chinese Urological Association (CUDA) was held from June 12–15 in the romantic city of Zhuhai. With the theme “Healthy China, Urology in Action,” the conference brought together experts from across the country to share the latest insights and practical experience in urologic surgery. At the conference, Professor Xuepei Zhang from the First Affiliated Hospital of Zhengzhou University delivered a compelling presentation titled “Clinical Application of Robotic Combined-Approach Radical Prostatectomy,” and further shared his institution’s experience in robotic-assisted urologic procedures with UroStream.

The 2025 Annual Meeting of the Chinese Urological Doctors Association (CUDA) was successfully held from June 12 to 15 in the romantic city of Zhuhai. With the theme “Healthy China, Urology in Action,” the conference gathered urological professionals from across the country to share cutting-edge knowledge and practical experience in the field. Professor Linhui Wang from the Department of Urology at Changhai Hospital, the First Affiliated Hospital of the Naval Medical University (Shanghai), shared with Oncology Frontier – UroStream the achievements and clinical insights of his team in genitourinary oncology.